Japanese Encephalitis Vaccine Suppliers & Bulk Manufacturers

Available Forms: Lyophilized powder, Pre-filled syringes

Available Strengths: 0.5 mL

Reference Brands: IXIARO(US)

Category: Vaccines

Japanese encephalitis vaccine stimulates immunity by introducing inactivated virus components, prompting the body to produce protective antibodies. It effectively prevents JE infection, reducing severe neurological complications. Benefits include long-lasting protection, safeguarding travelers and endemic communities, and supporting disease control efforts to eliminate Japanese encephalitis-related morbidity and mortality. Japanese Encephalitis Vaccine is available in Lyophilized powder, Pre-filled syringes and strengths such as 0.5 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Japanese Encephalitis Vaccine is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Japanese Encephalitis Vaccine can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Japanese Encephalitis (JE) vaccine is approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and quality in compliance with GMP standards. In the US, Ixiro approval involves extensive clinical data, while in the EU, CE marking certifies conformity with in vitro diagnostic regulations. Vaccines undergo validation, stability testing, and rigorous audits, with comprehensive documentation including safety profiles, clinical trial outcomes, and manufacturing practices. For licensing procedures, approved dossiers, and regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective JE vaccines essential for travelers and high-risk populations, supporting global efforts to prevent Japanese encephalitis outbreaks.